Ledger.Open graph →
SEC Form D · filed June 26, 2018

Mistral Therapeutics, Inc

Offering
$59.3M
Sold
$25.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Amos Epstein · Somerville, MADirectorJohn Walecka · San Francisco, CADirectorIgal L. Litovsky · New York, NYDirectorDavid Gagnon · Somerville, MADirectorDavid Nikodem · San Diego, CADirectorJeremy Caldwell · SAN DIEGO, CAExecJeremy Caldwell · SAN DIEGO, CAExecDiane Frank · Jurupa Valley, CADirectorJerel Davis · SAN DIEGO, CADirectorClare Ozawa · SAN DIEGO, CADirectorPetpiboon Prasit · SAN DIEGO, CADirectorBradley Bolzon · SAN DIEGO, CADirectorNicholas Mashburn · Somerville, MADirectorArthur K. Karas · Akron, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗